24.61USDMkt Cap: 1.15B USDP/E: —Last update: 2026-05-22
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as M…
Industry Peers
Medical Devices152.25BUSDP/E 24.5
85.88BUSDP/E 24.2
53.45BSEKP/E 22.6
53.33BSEKP/E 98.9
52.13BDKKP/E 22.1
38.61BEURP/E 18.3
23.15BSEK—
22.25BEURP/E 23.4
loading…
Indicators:|
Key Statistics
Company
Market Cap1.15B USD
Enterprise Value1.23B USD
Revenue (TTM)715.90M USD
Gross Profit353.90M USD
Net Income (TTM)-72.90M USD
Revenue/Share15.43 USD
Last Price24.61 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.3K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS05350V1061
Valuation
P/E (Trailing)—
P/E (Forward)19.76
PEG—
EV/EBITDA21.99
EV/Revenue1.72
P/S1.62
P/B1.47
EPS (TTM)-1.60
EPS (Forward)1.25
52W Range
24.5532% of range24.74
52W High24.74 USD
52W Low24.55 USD
Profitability
Gross Margin50.47%
Oper. Margin5.38%
EBITDA Margin7.81%
Profit Margin-10.40%
ROE-9.37%
ROA-6.79%
Growth
Revenue Growth8.80%
Earnings Growth-21.70%
Cash Flow & Leverage
Operating CF74.70M USD
CapEx (TTM)31.60M USD
FCF Margin2.38%
FCF Yield1.48%
Net Debt72.80M USD
Net Debt/EBITDA1.30
Balance Sheet
Debt/Equity0.17
Current Ratio2.48
Quick Ratio1.28
Book Value/Sh16.76 USD
Cash/Share1.401 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.46.82M
Float45.61M
Insiders4.75%
Institutions90.76%
Short Interest
Short Ratio0.6d
Short % Float3.46%
Short % Out.2.59%
Shares Short1.21M
Short (prev mo.)2.17M
Technical
SMA 5019.88 (+23.8%)
SMA 20014.07 (+74.9%)
Beta1.59
S&P 52W Chg28.31%
Avg Vol (30d)3.38M
Avg Vol (10d)949.49K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—